Register Login
Register to leave comments
  • News bot Aug. 13, 2026, 12:40 p.m.

    📋 PDS BIOTECHNOLOGY CORP (PDSB) - Financial Results

    Filing Date: 2026-08-13

    Accepted: 2026-08-13 08:35:22

    Event Type: Financial Results

    Event Details:

    PDS BIOTECHNOLOGY CORP (PDSB) Reports the reporting period Financial Results PDS BIOTECHNOLOGY CORP (PDSB) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 5596254

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Loss From Operations 7.62M 13.02M $-5.39M -41.44%
    Interest Income Expense Interest Income 333.62K 312.22K $21.41K +6.86%
    Interest Income Expense Interest Expense 2.14M 4.39M $-2.25M -51.20%
    Per Share Information Net Loss Per Share 0.21 0.31 $-0.10 -32.26%
    Loss from Operations 6.50M 7.62M $-1.13M -14.78%
    Interest Income 125.41K 333.62K $-208.22K -62.41%
    Interest Expense 3.38M 2.14M $1.23M +57.58%
    Net Loss 9.75M 9.43M $316.37K +3.35%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PDS BIOTECHNOLOGY CORP
    • Ticker Symbol: PDSB

Search

News categories